Alexander T. Shulgin

Author

Also Known As

A SHULGIN, A Shulgin, A T Shulgin, A. T. SHULGIN, A. T. Shulgin, A.T. Shulgin, ALEXANDER T. SHULGIN, Alexander Shulgin, Alexander T Shulgin, Alexander T. Shulgin

169

Publications

6.1K

Citations

H-Index

131

Concepts

All Affiliations

Dow Chemical (United States)University of California, San Francisco University of California, Berkeley San Francisco General Hospital Dow Chemical (India)

About

Alexander T. Shulgin is an author at Dow Chemical (United States) specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	42	2.2K
2	Natural Sciences	16	21	742
3	Engineering	15	18	590
4	Health Sciences	5	5	246
5	Language Studies	1	1	22

Alexander T. Shulgin

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue Michael H. Baumann, Mario Ayestas, John S. Partilla, Neuropsychopharmacology Psychoactive DrugMonoamine TransportersNeurophysiologyMedicineNeurotransmitter	2011	431
A convenient synthesis of quinones from hydroquinone dimethyl ethers. Oxidative demethylation with ceric ammonium nitrate Peyton Jacob, Patrick S. Callery, Alexander T. Shulgin, The Journal of Organic Chemistry Derivative (Chemistry)Hydroquinone Dimethyl EthersPharmacologyAltmetric Attention ScoreOrganic Chemistry	1976	284
Structure–Activity Relationships of One-Ring Psychotomimetics Alexander T. Shulgin, Thornton Sargent, Claudio A. Naranjo Nature Neurobiological MechanismNeuropsychologyPsychopharmacologyNeuroscienceStructure–activity Relationships	1969	242
Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines Nicholas V. Cozzi, Michael K. Sievert, Alexander T. Shulgin, European Journal of Pharmacology Molecular PharmacologyMedicinePhysiologyMonoamine NeurotransmittersNeurotransmitter	1999	192
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class David E. Nichols, Andrew J. Hoffman, Robert Oberlender, Journal of Medicinal Chemistry	1986	189
Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Peyton Jacob, Lisa Yu, Alexander T. Shulgin, American Journal of Public Health	1999	167
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter Nicholas V. Cozzi, Anupama Gopalakrishnan, Lyndsey L. Anderson, Journal of Neural Transmission NeurophysiologyVesicle Monoamine TransporterMedicinePhysiologyMonoamine Neurotransmitters	2009	141
Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine) U. Braun, Alexander T. Shulgin, Gisela Braun Journal of Pharmaceutical Sciences Pharmaceutical ChemistryOrganic ChemistryPharmacologyActive N-substituted AnalogsSynthetic Chemistry	1980	139
Intramolecular Hydrogen Bonds to π-Electrons and Other Weakly Basic Groups A. W. Baker, Alexander T. Shulgin Journal of the American Chemical Society EngineeringAltmetric Attention ScoreOrganic ChemistryChemistryIntramolecular Hydrogen Bonds	1958	119
Recent studies of nicotine metabolism in humans Peyton Jacob, Neal L. Benowitz, Alexander T. Shulgin Pharmacology Biochemistry and Behavior Tobacco CessationTobacco ControlTobacco UseAddictionMedicine	1988	103

Page 1